MPS Pharmaa Limited (BOM:531686)
India · Delayed Price · Currency is INR 1.680
-0.080 (-4.55%)
At close: Jan 12, 2026
MPS Pharmaa Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | - | - | - | - | 0.32 | - | Upgrade |
Other Revenue | 0.44 | 0.48 | 0.94 | 0.23 | 0 | - | Upgrade |
| 0.44 | 0.48 | 0.94 | 0.23 | 0.33 | - | Upgrade | |
Revenue Growth (YoY) | 586.68% | -49.05% | 302.00% | -28.85% | - | - | Upgrade |
Cost of Revenue | 0.18 | 0.18 | 0.28 | 2.09 | 0.61 | 0.07 | Upgrade |
Gross Profit | 0.26 | 0.3 | 0.66 | -1.86 | -0.28 | -0.07 | Upgrade |
Selling, General & Admin | 5.27 | 5.29 | 5.32 | 4.96 | 4.26 | 4.07 | Upgrade |
Other Operating Expenses | 2.16 | 2.17 | 2.39 | 2.43 | 2.19 | 37.16 | Upgrade |
Operating Expenses | 8.9 | 8.92 | 9.17 | 8.84 | 11.59 | 46.79 | Upgrade |
Operating Income | -8.64 | -8.63 | -8.51 | -10.7 | -11.86 | -46.86 | Upgrade |
Interest Expense | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | Upgrade |
Interest & Investment Income | - | - | - | - | 0.04 | 0.03 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | -0 | -0.01 | -0.01 | -0.01 | 0.16 | Upgrade |
EBT Excluding Unusual Items | -8.66 | -8.64 | -8.53 | -10.71 | -11.86 | -46.69 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.75 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 | Upgrade |
Other Unusual Items | - | - | - | - | 2.54 | - | Upgrade |
Pretax Income | -8.66 | -8.64 | -8.53 | -10.71 | -9.32 | -44.94 | Upgrade |
Income Tax Expense | 0.29 | 0.34 | -0.22 | -0.21 | -7.91 | -0.78 | Upgrade |
Net Income | -8.94 | -8.98 | -8.31 | -10.5 | -1.42 | -44.17 | Upgrade |
Net Income to Common | -8.94 | -8.98 | -8.31 | -10.5 | -1.42 | -44.17 | Upgrade |
Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 19 | 19 | Upgrade |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 19 | 19 | Upgrade |
Shares Change (YoY) | 0.41% | - | - | - | - | - | Upgrade |
EPS (Basic) | -0.47 | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 | Upgrade |
EPS (Diluted) | -0.47 | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 | Upgrade |
Free Cash Flow | -5.5 | -5.7 | -6.5 | -9.83 | -43.52 | -9.31 | Upgrade |
Free Cash Flow Per Share | -0.29 | -0.30 | -0.34 | -0.51 | -2.28 | -0.49 | Upgrade |
Gross Margin | 59.05% | 62.49% | 70.12% | - | -85.02% | - | Upgrade |
Operating Margin | -1976.87% | -1807.60% | -908.98% | -4591.68% | -3623.19% | - | Upgrade |
Profit Margin | -2045.95% | -1881.58% | -887.23% | -4508.10% | -432.36% | - | Upgrade |
Free Cash Flow Margin | -1257.87% | -1194.34% | -694.10% | -4218.27% | -13289.06% | - | Upgrade |
EBITDA | -7.18 | -7.16 | -7.05 | -9.24 | -6.73 | -41.3 | Upgrade |
D&A For EBITDA | 1.47 | 1.47 | 1.47 | 1.46 | 5.14 | 5.56 | Upgrade |
EBIT | -8.64 | -8.63 | -8.51 | -10.7 | -11.86 | -46.86 | Upgrade |
Revenue as Reported | 0.44 | 0.48 | 0.94 | 0.23 | 2.91 | 1.95 | Upgrade |
Advertising Expenses | - | 0.04 | 0.04 | 0.08 | 0.05 | 0.05 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.